ArticleCrohn's & colitis 3602024

Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan.

Katsumasa Nagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.